Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma-Reference-Cited by-同舟云学术

Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma

Published:2018-03 Issue:3 Volume:155 Page:1212-1224.e3
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Brandt Whitney S.,Bouabdallah Ilies,Tan Kay See,Park Bernard J.,Adusumilli Prasad S.,Molena Daniela,Bains Manjit S.,Huang James,Isbell James M.,Bott Matthew J.,Jones David R.

Funder

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference37 articles.

1. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer;Goldstraw;J Thorac Oncol,2016

2. Long-term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database;Paul;BMJ,2014

3. Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgery;Hancock;Ann Thorac Surg,2015

4. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group;Ginsberg;Ann Thorac Surg,1995

5. Choice of surgical procedure for patients with non–small cell lung cancer ≤1 cm or >1 to 2 cm among lobectomy, segmentectomy, and wedge resection: a population-based study;Dai;J Clin Oncol,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-cell death-related signature reveals tumor immune microenvironment and optimizes personalized therapy alternations in lung adenocarcinoma;Scientific Reports;2024-07-08

2. Late recurrence of completely resected stage I to IIIA lung adenocarcinoma;The Journal of Thoracic and Cardiovascular Surgery;2024-06

3. High-risk features associated with recurrence in stage I lung adenocarcinoma;The Journal of Thoracic and Cardiovascular Surgery;2024-05

4. A Pathologically Friendly Strategy for Determining the Organ‐specific Spatial Tumor Microenvironment Topology in Lung Adenocarcinoma Through the Integration of snRandom‐seq and Imaging Mass Cytometry;Advanced Science;2024-04-29

5. A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma;BMC Cancer;2023-09-11